WallStreetZenWallStreetZen

NASDAQ: ANIX
Anixa Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANIX

Based on 3 analysts offering 12 month price targets for Anixa Biosciences Inc

Min Forecast
$7.00+108.96%
Avg Forecast
$9.00+168.66%
Max Forecast
$10.00+198.51%

Should I buy or sell ANIX stock?

Based on 3 analysts offering ratings for Anixa Biosciences Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANIX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ANIX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ANIX stock forecasts and price targets.

ANIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-11
lockedlocked$00.00+00.00%2025-09-09
lockedlocked$00.00+00.00%2025-03-21

1 of 1

Forecast return on equity

Is ANIX forecast to generate an efficient return?

Company
N/A
Industry
71.88%
Market
-21.43%

Forecast return on assets

Is ANIX forecast to generate an efficient return on assets?

Company
N/A
Industry
23.46%

ANIX earnings per share forecast

What is ANIX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.38

ANIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANIX$3.35$9.00+168.66%Strong Buy
FATE$0.95$2.83+198.21%Buy
CGTX$1.47$3.50+138.10%Strong Buy
IOBT$1.71$8.00+367.84%Strong Buy
ARMP$2.96$9.00+204.05%Buy
View Top Biotech Stocks

Anixa Biosciences Stock Forecast FAQ

Is Anixa Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ANIX) stock is to Strong Buy ANIX stock.

Out of 3 analysts, 2 (66.67%) are recommending ANIX as a Strong Buy, 1 (33.33%) are recommending ANIX as a Buy, 0 (0%) are recommending ANIX as a Hold, 0 (0%) are recommending ANIX as a Sell, and 0 (0%) are recommending ANIX as a Strong Sell.

If you're new to stock investing, here's how to buy Anixa Biosciences stock.

What is ANIX's earnings growth forecast for 2025-2026?

(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.28%.

Anixa Biosciences's earnings in 2025 is -$11,115,000.On average, 1 Wall Street analyst forecast ANIX's earnings for 2025 to be -$11,520,920, with the lowest ANIX earnings forecast at -$11,520,920, and the highest ANIX earnings forecast at -$11,520,920.

In 2026, ANIX is forecast to generate -$12,508,428 in earnings, with the lowest earnings forecast at -$12,508,428 and the highest earnings forecast at -$12,508,428.

What is ANIX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ANIX) forecast ROE is N/A, which is considered weak.

What is ANIX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ANIX price target, the average ANIX price target is $9.00, with the highest ANIX stock price forecast at $10.00 and the lowest ANIX stock price forecast at $7.00.

On average, Wall Street analysts predict that Anixa Biosciences's share price could reach $9.00 by Sep 11, 2026. The average Anixa Biosciences stock price prediction forecasts a potential upside of 168.66% from the current ANIX share price of $3.35.

What is ANIX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ANIX) Anixa Biosciences's current Earnings Per Share (EPS) is -$0.35. On average, analysts forecast that ANIX's EPS will be -$0.35 for 2025, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.35. In 2026, ANIX's EPS is forecast to hit -$0.38 (min: -$0.38, max: -$0.38).

What is ANIX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ANIX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 23.46%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.